| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2010PLoSO...512211V |
| P356 | DOI | 10.1371/JOURNAL.PONE.0012211 |
| P932 | PMC publication ID | 2923181 |
| P698 | PubMed publication ID | 20808916 |
| P5875 | ResearchGate publication ID | 46108662 |
| P50 | author | François Chappuis | Q28817156 |
| Manu Vanaerschot | Q28817160 | ||
| Saskia Decuypere | Q28817166 | ||
| P2093 | author name string | Jean-Claude Dujardin | |
| Suman Rijal | |||
| Louis Maes | |||
| Simonne De Doncker | |||
| Ilse Maes | |||
| Vanessa Adaui | |||
| Meriem Ouakad | |||
| P2860 | cites work | Quorum Sensing in Bacteria | Q22255618 |
| Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic | Q28142100 | ||
| Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani | Q28271918 | ||
| Redox control in trypanosomatids, parasitic protozoa with trypanothione-based thiol metabolism | Q28275518 | ||
| Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? | Q29038941 | ||
| qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data | Q29616810 | ||
| Leishmania interferes with host cell signaling to devise a survival strategy | Q33781265 | ||
| Differentiation of African trypanosomes is controlled by a density sensing mechanism which signals cell cycle arrest via the cAMP pathway. | Q51099856 | ||
| Treatment of visceral leishmaniasis in south-eastern Nepal: decreasing efficacy of sodium stibogluconate and need for a policy to limit further decline. | Q53891579 | ||
| Antimonial treatment of visceral leishmaniasis: are current in vitro susceptibility assays adequate for prognosis of in vivo therapy outcome? | Q56558896 | ||
| Antigenic variation in syringe passaged populations of Trypanosoma (Trypanozoon) brucei. 1. Rationalization of the experimental approach | Q67393574 | ||
| A simple monophasic medium for axenic culture of hemoflagellates | Q67484350 | ||
| Metacyclogenesis of Leishmania spp: species-specific in vitro transformation, complement resistance, and cell surface carbohydrate and protein profiles | Q70169989 | ||
| Quorum sensing and starvation: signals for entry into stationary phase | Q33879812 | ||
| Trypanothione Reductase from Leishmania donovani. Purification, Characterisation and Inhibition by Trivalent Antimonials | Q34058179 | ||
| Sodium antimony gluconate induces generation of reactive oxygen species and nitric oxide via phosphoinositide 3-kinase and mitogen-activated protein kinase activation in Leishmania donovani-infected macrophages | Q34648790 | ||
| Early mechanisms of Leishmania infection in human blood | Q35132142 | ||
| Copper toxicity, oxidative stress, and antioxidant nutrients | Q35160397 | ||
| New insights into the developmental biology and transmission mechanisms of Leishmania. | Q35882552 | ||
| Leishmania donovani engages in regulatory interference by targeting macrophage protein tyrosine phosphatase SHP-1. | Q36049321 | ||
| Increased levels of thiols protect antimony unresponsive Leishmania donovani field isolates against reactive oxygen species generated by trivalent antimony | Q36133198 | ||
| Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani | Q36367801 | ||
| Phlebotomine sand flies and Leishmania parasites: friends or foes? | Q36537320 | ||
| Metacyclogenesis is a major determinant of Leishmania promastigote virulence and attenuation | Q37008099 | ||
| In vitro susceptibility of field isolates of Leishmania donovani to Miltefosine and amphotericin B: correlation with sodium antimony gluconate susceptibility and implications for treatment in areas of endemicity | Q37072017 | ||
| Antibiotic resistance and its cost: is it possible to reverse resistance? | Q37704177 | ||
| Oxidative effects of heme and porphyrins on proteins and lipids. | Q38637448 | ||
| Epidemiological dynamics of antimonial resistance in Leishmania donovani: genotyping reveals a polyclonal population structure among naturally-resistant clinical isolates from Nepal | Q39162585 | ||
| Influence of the inoculation route in BALB/c mice infected by Leishmania infantum | Q39406694 | ||
| Real-time PCR for detection and quantitation of leishmania in mouse tissues | Q39665264 | ||
| Leishmania GP63 alters host signaling through cleavage-activated protein tyrosine phosphatases. | Q39792607 | ||
| Lower nitric oxide susceptibility of trivalent antimony-resistant amastigotes of Leishmania infantum | Q40367948 | ||
| The role of pH and temperature in the development of Leishmania parasites | Q40572964 | ||
| Pro-oxidative vs antioxidative properties of ascorbic acid in chromium(VI)-induced damage: an in vivo and in vitro approach | Q44022808 | ||
| Antigen genes for molecular epidemiology of leishmaniasis: polymorphism of cysteine proteinase B and surface metalloprotease glycoprotein 63 in the Leishmania donovani complex | Q44785806 | ||
| Skewing of cytokine profiles towards T helper cell type 2 response in visceral leishmaniasis patients unresponsive to sodium antimony gluconate | Q44983128 | ||
| Sodium stibogluconate resistance in Leishmania donovani correlates with greater tolerance to macrophage antileishmanial responses and trivalent antimony therapy | Q46841786 | ||
| Identification of leishmania fructose-1,6-bisphosphate aldolase as a novel activator of host macrophage Src homology 2 domain containing protein tyrosine phosphatase SHP-1. | Q46889356 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Leishmania donovani | Q1950752 |
| P304 | page(s) | e12211 | |
| P577 | publication date | 2010-08-17 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Linking in vitro and in vivo survival of clinical Leishmania donovani strains | |
| P478 | volume | 5 |
| Q28476400 | Antimonial resistance in Leishmania donovani is associated with increased in vivo parasite burden |
| Q37390629 | Antimony resistance and environment: Elusive links to explore during Leishmania life cycle. |
| Q36616938 | Antimony-resistant but not antimony-sensitive Leishmania donovani up-regulates host IL-10 to overexpress multidrug-resistant protein 1. |
| Q28543757 | Arsenic exposure and outcomes of antimonial treatment in visceral leishmaniasis patients in Bihar, India: a retrospective cohort study |
| Q28550306 | Comparative Fitness of a Parent Leishmania donovani Clinical Isolate and Its Experimentally Derived Paromomycin-Resistant Strain |
| Q27009505 | Comparative analysis of the omics technologies used to study antimonial, amphotericin B, and pentamidine resistance in leishmania |
| Q34660710 | Correlation between glucose uptake and membrane potential in Leishmania parasites isolated from DCL patients with therapeutic failure: a proof of concept |
| Q38040818 | Drug-resistant microorganisms with a higher fitness--can medicines boost pathogens? |
| Q93378230 | Elucidating in vitro and in vivo phenotypic behaviour of L. infantum/L. major natural hybrids |
| Q37712969 | Elucidation of cellular mechanisms involved in experimental paromomycin resistance in Leishmania donovani |
| Q39014583 | Evaluating drug resistance in visceral leishmaniasis: the challenges |
| Q42277296 | Evaluation of Correlation between the In Vitro Susceptibility of Field Isolates of Leishmania major and Clinical Outcomes of Meglumine Antimoniate Therapy in Fars Province, Iran |
| Q53120855 | Evidence of a drug-specific impact of experimentally selected paromomycin and miltefosine resistance on parasite fitness in Leishmania infantum. |
| Q87248184 | Frequency of MDR1-related p-gp overexpression in Greek Leishmania isolates |
| Q34017586 | Genetic markers for SSG resistance in Leishmania donovani and SSG treatment failure in visceral leishmaniasis patients of the Indian subcontinent |
| Q57177294 | Genome Plasticity in Cultured : Comparison of Early and Late Passages |
| Q35861438 | Genome-wide SNP and microsatellite variation illuminate population-level epidemiology in the Leishmania donovani species complex |
| Q52566647 | Genomic and transcriptomic alterations in Leishmania donovani lines experimentally resistant to antileishmanial drugs. |
| Q38083295 | HIV-1 protease inhibitors for treatment of visceral leishmaniasis in HIV-co-infected individuals |
| Q57929890 | Importance of secondary screening with clinical isolates for anti-leishmania drug discovery |
| Q38953715 | In vitro and in vivo behaviour of sympatric Leishmania (V.) braziliensis, L. (V.) peruviana and their hybrids |
| Q39124054 | In vivo characterization of two additional Leishmania donovani strains using the murine and hamster model. |
| Q39330359 | Increased metacyclogenesis of antimony-resistant Leishmania donovani clinical lines |
| Q37907925 | Leishmania antimony resistance: what we know what we can learn from the field. |
| Q34058373 | Leishmanicidal activities of novel synthetic furoxan and benzofuroxan derivatives |
| Q38904947 | Metabolic adaptations of Leishmania donovani in relation to differentiation, drug resistance, and drug pressure |
| Q52579703 | Molecular Preadaptation to Antimony Resistance in Leishmania donovani on the Indian Subcontinent. |
| Q24611966 | Relapse after treatment with miltefosine for visceral leishmaniasis is associated with increased infectivity of the infecting Leishmania donovani strain |
| Q36385616 | Studies in the mouse model identify strain variability as a major determinant of disease outcome in Leishmania infantum infection |
| Q38209866 | Treatment failure in leishmaniasis: drug-resistance or another (epi-) phenotype? |
| Q28484459 | Treatment of visceral leishmaniasis: model-based analyses on the spread of antimony-resistant L. donovani in Bihar, India |
| Q34043521 | Visceral leishmaniasis and arsenic: an ancient poison contributing to antimonial treatment failure in the Indian subcontinent? |
| Q24633552 | Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance |
Search more.